A breath of pressurized, oxygen-rich air can change the lives of patients with PTSD and many other conditions.

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

Bempedoic acid has a novel mechanism of action that inhibits a cholesterol synthesis pathway by acting on ATP (adenosine triphosphate) citrate lyase, a citrate-degrading enzyme in the liver. Bempedoic ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Treatment involves addressing the underlying deficiency through dietary changes, supplementation, or medical interventions, aiming to restore normal red blood cell production and alleviate symptoms of ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Although not guideline-approved, screening for iron deficiency in patients with risk factors could prevent progression to ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.